Mativ Business Model Canvas

Alliances with downstream converters and label producers ensure end-use performance in release liners and packaging, supporting validation across adhesion, release force and printability through joint trials. These collaborations expanded Mativ’s reach into new markets and SKUs, contributing to growth as the global release liner market reached about $6.2 billion in 2024. Feedback loops from converters drive product refinements and launch of targeted SKUs, shortening development cycles and reducing field defects.

Strategic supplier and OEM alliances secure inputs and scale-up, de-risking supply and supporting 2024 continuity targets. Converter and clinical partner networks accelerate commercialization and regulatory clearance (ISO 13485, FDA 510(k)/PMA, EU MDR). Logistics and sustainability partners cut lead times and emissions while enabling market expansion.

Advanced manufacturing & QA integrate precision coating, extrusion, meltblown and calendaring at scale with inline inspection and SPC ensuring tight tolerances. Lot-level traceability and CoA issuance enable product release and regulatory compliance. Continuous improvement programs focus on yield enhancement and scrap reduction through root-cause analysis and process control.

Formulation targets N95-level 95% capture at 0.3 µm, release performance and healthcare compatibility. Lab testing covers mechanical, chemical and thermal validation; rapid prototyping and pilot runs enable scale-up. Compliance with ISO 13485, FDA 21 CFR Part 820, ISO 9001/14001 and REACH guides documentation and QA. Global sourcing emphasizes dual-sourcing, hedging and VMI; 2024 LCA supports sustainability claims.

Materials scientists, process engineers, and application specialists drive materials innovation and scale-up, supporting product performance in high-value segments.

Trained operators maintain tight tolerances on multi-million-dollar continuous lines, reducing scrap and preserving yields in high-spec manufacturing.

Quality and regulatory experts ensure compliance with ISO 13485 and FDA 21 CFR 820 for healthcare products targeting a >$500 billion global medtech market (2024 est.).

Global sales engineers translate technical specs into commercial value, shortening customer qualification cycles and expanding OEM engagements.

Patents, process know-how and specialized lines (coating, meltblown, extrusion) support scale and yield; application data libraries accelerate development in a global filtration market ≈ $78B (2024). Healthcare compliance targets a >$500B medtech market (2024); >70% recurring demand via OEM approvals and 3–5 year contracts stabilizes revenues.

Mativ offers recycled, bio-based and lighter-weight constructions that cut material use and logistics costs; in 2024 over 70% of consumers favored sustainable brands, driving demand for verified solutions. Certifications such as GRS, FSC, Cradle to Cradle and ISO 14001 plus third-party LCAs substantiate ESG claims. Process efficiencies reduce waste and energy use, and credible sustainability credentials enable clear brand differentiation.

Engineered products deliver consistent, durable performance with ISO/ASTM validation and tight specs, reducing batch variability and scrap. Tailored media/liners cut qualification time up to 40% and support retention gains ~20% in adhesive/specialty films ($60B market, 2024). Sustainable constructions meet GRS/FSC/Cradle-to-Cradle, favored by >70% consumers in 2024; OTIF >95% cuts non-conformance costs ~30%.

Mativ centralizes shared documentation and audit trails, streamlining CAPA workflows to accelerate corrective actions. In 2024 Mativ expanded regulatory collaboration across North America and the EU, providing proactive change-control communication for line and spec updates. The team supports customer certifications and filings, integrating evidence for inspections. This reduces customers' compliance burden and shortens review cycles.

Hands-on engineering support, on-site trials and <24-hour responses drove a 72% higher purchase conversion in 2024, accelerating adoption and reducing time-to-qualify.

Key-account QBRs, SLAs and KPIs focus top 20% accounts that deliver ~80% revenue, enabling upsell and roadmap alignment.

VMI/consignment cut inventory 20–30% and stockouts 50%; digital tracking 64% adoption improved OTIF and reduced inquiries.

Digital portal and e-commerce host product catalogs, datasheets, and sample requests online while enabling order placement and status tracking, streamlining procurement for customers. Technical resources and calculators support rapid, accurate selection and reduce engineering touchpoints. According to Gartner 2024, about 70% of B2B buyers prefer digital channels, helping cut sales friction and accelerate decision cycles.

Direct enterprise sales, regional distributors/converters, digital portal/e-commerce, events/standards, and inside sales form Mativs omni-channel mix, balancing long-cycle technical deals with fast digital procurement; 2024 revenue ~2.9B supports direct model while ~70% B2B prefer digital, and events feed high-quality leads.

Label, tape and packaging converters use release liners, facestocks and specialty substrates and demand controlled release, caliper and surface energy to ensure adhesion and runnability. They require clean converting and high printability for multi-SKU jobs; short runs (often <5,000 units) dominate workflows and raise changeover costs by ~20–30%. The global labelstock market was ~USD 12 billion in 2024 and converters typically target 5–10% EBIT margins while serving food, pharma, and industrial end-markets.

Filtration OEMs, medtech, converters, industrial/electronics and personal care brands require certified, traceable, high-performance substrates with supply continuity; 2024 market refs: medtech 520B, labelstock 12B, personal care 495B. Typical behaviors: multi-year contracts, 6–18 month quals, OTIF >99%, short converter runs <5k.

Labor and overhead cover skilled operators, engineers, QA, and sales teams plus training and safety programs to meet manufacturing and regulatory standards. Corporate functions and IT systems support operations and scalability. Benefits and compliance costs are included; employer benefit costs averaged 31.4% of total compensation in March 2024 (BLS).

Raw materials (PP/PE $1,100–1,600/t; BSKP $900–1,300/t in 2024), energy (US power ~7¢/kWh; HH gas ~$3/MMBtu) and labor (employer cost ~31.4% of pay) drive COGS; hedges cover ~60–80% volumes. Maintenance 3–5% plant value, depreciation 7–10 yr, debottlenecking 0.5–2% rev, pilot lines 0.1–0.5% rev. Carbon costs: EU ~85 €/tCO2 in 2024.

Value-added converting and services — slitting, laminating, coating customization and kitting — allow Mativ to charge premiums for tight tolerances and special packaging, often capturing up to 15–20% higher ASPs in 2024 industry benchmarks. Tolling for customer-supplied materials reduces capital intensity and boosts customer stickiness, with service-led contracts seen to raise retention ~10–15% in recent sector analyses. These capabilities support margin expansion and differentiated revenue streams.

Primary revenue from specialty roll goods ≈70% of 2024 sales, with value-added services delivering +15–20% ASP premiums. Long-term supply agreements cover ≈40% of volumes and stabilize margins via price-adjustment clauses. Licensing and tech-transfer accounted for ≈6% of 2024 revenue with gross margins >50%.